<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; Infectious Diseases</title>
	<atom:link href="http://pharmaexecnews.com/category/pharmaceuticals/infectious-diseases/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmaexecnews.com</link>
	<description></description>
	<lastBuildDate>Fri, 29 Apr 2011 14:00:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Low Sunlight Exposure and Common Virus Responsible for Multiple Sclerosis</title>
		<link>http://pharmaexecnews.com/biotechnology/biomedical/sunlight-exposure-common-virus-responsible-multiple-sclerosis/</link>
		<comments>http://pharmaexecnews.com/biotechnology/biomedical/sunlight-exposure-common-virus-responsible-multiple-sclerosis/#comments</comments>
		<pubDate>Tue, 26 Apr 2011 14:00:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Virus]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11514</guid>
		<description><![CDATA[New research has indicated that people who are exposed to very low levels of sunlight and who also have a history of having a common virus known as mononucleosis, are at greater odds of developing multiple sclerosis (MS) than those without the virus.

According to George C. Ebers, MD, with the University of Oxford in the [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/biomedical/sunlight-exposure-common-virus-responsible-multiple-sclerosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Possible Breakthrough in Battle against AIDS: Protein Fragment Blocks AIDS Virus Entry into Cells</title>
		<link>http://pharmaexecnews.com/biotechnology/breakthrough-battle-aids-protein-fragment-blocks-aids-virus-entry-cells/</link>
		<comments>http://pharmaexecnews.com/biotechnology/breakthrough-battle-aids-protein-fragment-blocks-aids-virus-entry-cells/#comments</comments>
		<pubDate>Thu, 14 Apr 2011 08:00:24 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Proteomics]]></category>
		<category><![CDATA[Virus]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11442</guid>
		<description><![CDATA[Researchers worldwide are hailing a new discovery as being a possible breakthrough in the treatment for AIDS. Scientists have developed a new protein that stops the AIDS the virus from entering cells. This protein has a basic make-up of naturally occurring proteins in the body that protects cells from viruses, except the human-made version does [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/breakthrough-battle-aids-protein-fragment-blocks-aids-virus-entry-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Impact of Parasitic Infection on Behavior</title>
		<link>http://pharmaexecnews.com/biotechnology/impact-parasitic-infection-behavior/</link>
		<comments>http://pharmaexecnews.com/biotechnology/impact-parasitic-infection-behavior/#comments</comments>
		<pubDate>Thu, 31 Mar 2011 14:00:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Infectious Diseases]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11399</guid>
		<description><![CDATA[A latest study conducted by Jianchun Xiao and colleagues at the Johns Hopkins School of Medicine has found distinct differences in the manipulation of host gene expression among the three clonal lineages of parasites that are found in Europe and North America.

The study found that in spite of the high levels of genetic similarity among [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/impact-parasitic-infection-behavior/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pancreatic Cancer to be Cured by Malarial Drug?</title>
		<link>http://pharmaexecnews.com/biotechnology/pancreatic-cancer-cured-malarial-drug/</link>
		<comments>http://pharmaexecnews.com/biotechnology/pancreatic-cancer-cured-malarial-drug/#comments</comments>
		<pubDate>Thu, 24 Mar 2011 14:00:46 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Oncology]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11365</guid>
		<description><![CDATA[In a recent breakthrough that holds the potential of slowing down the growth of pancreatic cancer, researchers from the Dana-Farber Cancer Institute have reported that they have shrunk or slowed the growth of notoriously resistant pancreatic tumors in mice, using a drug routinely prescribed for malaria and rheumatoid arthritis.

The pre-clinical results are already creating a [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/pancreatic-cancer-cured-malarial-drug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Nanoparticles from MIT could lead to Vaccines for HIV, Malaria and Others</title>
		<link>http://pharmaexecnews.com/pharmaceuticals/drug-discovery/nanoparticles-mit-lead-vaccines-hiv-malaria/</link>
		<comments>http://pharmaexecnews.com/pharmaceuticals/drug-discovery/nanoparticles-mit-lead-vaccines-hiv-malaria/#comments</comments>
		<pubDate>Fri, 11 Mar 2011 08:00:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Nanotechnology]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[nano]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[nanotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11275</guid>
		<description><![CDATA[While it might seem unbelievable, MIT engineers have announced that they have managed to design a new type of nanoparticles that could effectively and safely deliver vaccines for diseases such as malaria and HIV. HIV is known to be one of the biggest killers in the world and till now no one has been able [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/pharmaceuticals/drug-discovery/nanoparticles-mit-lead-vaccines-hiv-malaria/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Transgenic Fungi to Treat Malaria</title>
		<link>http://pharmaexecnews.com/biotechnology/transgenic-fungi-treat-malaria/</link>
		<comments>http://pharmaexecnews.com/biotechnology/transgenic-fungi-treat-malaria/#comments</comments>
		<pubDate>Thu, 10 Mar 2011 14:29:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11268</guid>
		<description><![CDATA[Many developing countries are fighting the battle against malaria, with thousands of people dying every year due to malaria.  Now, new research from the University of  Maryland has indicated that a genetically engineered fungus might actually be able to cure malaria. The research team has proposed that a genetically engineered fungus carrying genes for [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/transgenic-fungi-treat-malaria/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Neglected Tropical Diseases in the Spotlight</title>
		<link>http://pharmaexecnews.com/biotechnology/neglected-tropical-diseases-spotlight/</link>
		<comments>http://pharmaexecnews.com/biotechnology/neglected-tropical-diseases-spotlight/#comments</comments>
		<pubDate>Tue, 08 Mar 2011 06:34:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Infectious Diseases]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11249</guid>
		<description><![CDATA[A new initiative has been launched in the Netherlands against neglected tropical diseases. Called as the European Solutions Enterprise for Neglected Diseases (euSEND), this is a joint initiative of the Academic Medical Center of the University of Amsterdam (AMC), the Amsterdam Institute for Global Health and Development (AIGHD), the Royal Tropical Institute (KIT), Roland Berger [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/neglected-tropical-diseases-spotlight/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Inhalable Measles Vaccine Tested</title>
		<link>http://pharmaexecnews.com/biotechnology/inhalable-measles-vaccine-tested/</link>
		<comments>http://pharmaexecnews.com/biotechnology/inhalable-measles-vaccine-tested/#comments</comments>
		<pubDate>Fri, 25 Feb 2011 08:00:43 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11197</guid>
		<description><![CDATA[Sustained high vaccination coverage is key to preventing deaths from measles. Despite the availability of a vaccine, measles remains an important killer of children worldwide, particularly in less-developed regions where vaccination coverage is limited. A team of researchers, led by scientists at the Johns Hopkins Bloomberg School of Public Health and the University of Colorado, [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/inhalable-measles-vaccine-tested/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GSK Malaria Vax Shows Promising Results</title>
		<link>http://pharmaexecnews.com/biotechnology/gsk-malaria-vax-shows-promising-results/</link>
		<comments>http://pharmaexecnews.com/biotechnology/gsk-malaria-vax-shows-promising-results/#comments</comments>
		<pubDate>Wed, 19 Jan 2011 08:00:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Companies]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11085</guid>
		<description><![CDATA[Mosquirix, an experimental malaria vaccine from GlaxoSmithKline, provides African children with long-lasting protection and reduces the risk of infection by the parasite that causes severe malaria by 46 percent over 15 months, according to researchers.

Between March 2007 and October 2008, the researchers enrolled healthy children between the ages of 5-17 months in Kenya and Tanzania. [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/gsk-malaria-vax-shows-promising-results/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>First HIV &#8220;Cure&#8221; Comes with a Very Big Catch</title>
		<link>http://pharmaexecnews.com/biotechnology/hiv-cure-big-catch/</link>
		<comments>http://pharmaexecnews.com/biotechnology/hiv-cure-big-catch/#comments</comments>
		<pubDate>Wed, 22 Dec 2010 08:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[understanding stem cell research]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11003</guid>
		<description><![CDATA[In a rare victory against AIDS, German scientists say that three years after a unique stem cell transplant was tried on a patient, &#8220;cure of HIV has been achieved in this&#8221; man. This is the first time anyone has been pronounced cured of the disease. But as New Scientist notes, their radical therapy strategy offers [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/hiv-cure-big-catch/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

